Jul 23, 09:09
Jul 23, 09:07
AnnouncementsAurobindo Pharma appoints Santhanam Subramanian as CFO
71% of moneycontrol users recommend buying Aurobindo Pharm.
What's your call on Aurobindo Pharm today?
Read 54 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2733.95||0.54||2939.80||2140.35||46,568.75|
|Mar' 14||Sep' 13||Jun' 13||Mar' 13|
AIA Engineering Recommended on May 7th 2014
Recommended price 642.00 | Peak from reco 858.00 33.64%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Aurobindo Pharm is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 20,967.42 crore.The company has reported a consolidated sales of Rs 2,305.88 crore and a Net Profit of Rs 501.63 crore for the quarter ended Mar 2014.
The company management includes K Ragunathan - Non Executive Chairman, K Nithyananda Reddy - Vice Chairman & Whole Time Dir, N Govindarajan - Managing Director, M Sivakumaran - Whole Time Director, M Madan Mohan Reddy - Whole Time Director, P V Ramprasad Reddy - Non Executive Director, P Sarath Chandra Reddy - Non Executive Director, M Sitarama Murthy - Non Executive Director, D Rajagopala Reddy - Non Executive Director, C Channa Reddy - Non Executive Director.
It is listed on the BSE with a BSE Code of 524804 and the NSE with an NSE Code of AUROPHARMA.
Its Registered office is at Plot No. 2, Maitrivihar,,Ameerpet Hyderabad,Andhra Pradesh - 500038.
Their Registrars are Karvy Computershare Private Ltd.